Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/1764
DC FieldValueLanguage
dc.contributor.authorKedev, Sashkoen_US
dc.contributor.authorAntov, Slobodanen_US
dc.contributor.authorTrajkov, Dejanen_US
dc.contributor.authorPetlichkovski, Aleksandaren_US
dc.contributor.authorDzhekova-Stojkova, Slobodaen_US
dc.contributor.authorKostovska, Stojankaen_US
dc.contributor.authorSpiroski, Mirkoen_US
dc.contributor.authorSpiroski, Igoren_US
dc.date.accessioned2019-03-21T11:30:03Z-
dc.date.available2019-03-21T11:30:03Z-
dc.date.issued2009-10-
dc.identifier.issn0022-9032-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/1764-
dc.description.abstractBACKGROUND: Raised SERPINE1 plasma levels are related to a 1-bp guanine deletion/insertion (4G5G) polymorphism in the promoter of the SERPINE1 (plasminogen activator inhibitor 1 - PAI1) gene. Evidence suggested that the plasma levels of SERPINE1 modulate the risk of coronary artery disease; furthermore, that the 4G5G polymorphism affects the expression of the SERPINE1 gene. AIM: To analyse association of SERPINE1 polymorphism with occlusive artery disease (OAD) and deep venous thrombosis (DVT) in Macedonians in order to investigate its role as a part of candidate genes in different vascular diseases in Macedonians. METHODS: Investigated groups consisted of 82 healthy patients, 75 with OAD, and 66 with DVT. Blood samples were collected after written informed consent was obtained, and DNA was isolated from peripheral blood leukocytes. Identification of SERPINE1 polymorphism was done with CVD StripAssay (ViennaLab, Labordiagnostica GmbH, Austria). The population genetics analysis package, PyPop, was used for analysis of the SERPINE1 data. Pearson's P-values, crude odds ratio and Wald's 95% CI were calculated with Bonferroni corrected p value. RESULTS: The frequency of 4G allele for SERPINE1 was 0.538 for DVT, 0.555 for healthy participants, and 0.607 for OAD. The frequency of 5G allele for SERPINE1 was the smallest in patients with OAD (0.393) and was higher in healthy participants (0.445), and patients with DVT (0.462). Test of neutrality (Fnd) showed negative value, but was significantly different from 0 for SERPINE1 in healthy participants (p of F = 0.041) and in patients with DVT (p of F = 0.030). SERPINE1 genotypes in healthy participants and patients with OAD were not in Hardy Weinberg proportions (p = 0.019 and 0.001, respectively). No association between SERPINE1 polymorphisms and OAD or DVT was found. CONCLUSION: There is no significant relationship between SERPINE1 polymorphisms and occlusive artery disease or deep venous thrombosis in Macedonian population.en_US
dc.language.isoenen_US
dc.publisherMedycyna Praktycznaen_US
dc.relation.ispartofKardiologia polskaen_US
dc.subjectSERPINE1 polymorphismen_US
dc.subjectocclusive artery diseaseen_US
dc.subjectdeep venous thrombosisen_US
dc.subjectMacedoniansen_US
dc.titleInvestigation of SERPINE1 genetic polymorphism in Macedonian patients with occlusive artery disease and deep vein thrombosisen_US
dc.typeArticleen_US
dc.identifier.volume67-
dc.identifier.issue10-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
Spiroski_I.pdf93.42 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

136
checked on Apr 18, 2024

Download(s)

29
checked on Apr 18, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.